Prescribed Freely Here, Restricted Abroad: What Global Regulatory Divergence Reveals About Azithromycin's Future
While azithromycin remains one of the most frequently dispensed antibiotics in the United States, health authorities in Europe, Australia, and other developed nations have moved to curtail its use through formal stewardship programs and prescribing guidelines. Understanding why these divergent regulatory paths emerged—and what they may ultimately mean for American patients—has become one of the more pressing questions in global antimicrobial policy.